Imricor Medical Systems (ASX:IMR) received CE Mark certification for its NorthStar mapping system under the European Union Medical Device Regulation, classifying it as a class IIa medical device, according to a Tuesday filing with the Australian bourse.
This approval allows the company to market NorthStar across Europe and the Middle East, the filing said.
Shares rose past 5% in morning trade Tuesday.